BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6431469)

  • 1. Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement.
    McElroy JF; Feldman RS
    Psychopharmacology (Berl); 1984; 83(2):172-8. PubMed ID: 6431469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors.
    Barrett RJ; Blackshear MA; Sanders-Bush E
    Psychopharmacology (Berl); 1982; 76(1):29-35. PubMed ID: 6805004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
    McCreary AC; Filip M; Cunningham KA
    Behav Neurosci; 2003 Apr; 117(2):212-21. PubMed ID: 12708517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat.
    Maurel S; Schreiber R; De Vry J
    Behav Pharmacol; 1998 Jul; 9(4):337-43. PubMed ID: 10065922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anorectic drugs in rats trained to discriminate between satiation and deprivation.
    Schechter MD
    Life Sci; 1990; 47(1):17-24. PubMed ID: 2388514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal differences in behavioral effect of fenfluramine and norfenfluramine.
    Schechter MD
    Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
    Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats.
    Shoaib M; Baumann MH; Rothman RB; Goldberg SR; Schindler CW
    Psychopharmacology (Berl); 1997 Jun; 131(3):296-306. PubMed ID: 9203241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfenfluramine, the fenfluramine metabolite, provides stimulus control: evidence for serotonergic mediation.
    Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1988 Oct; 31(2):305-11. PubMed ID: 3244707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.
    Goudie AJ; Atkinson J; West CR
    Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats.
    Marona-Lewicka D; Nichols DE
    Behav Pharmacol; 2011 Sep; 22(5-6):508-15. PubMed ID: 21814134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement.
    McElroy JF; O'Donnell JM
    J Pharmacol Exp Ther; 1988 Apr; 245(1):155-63. PubMed ID: 2834535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination.
    Goodwin AK; Pynnonen DM; Baker LE
    Pharmacol Biochem Behav; 2003 Mar; 74(4):987-95. PubMed ID: 12667914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of fenfluramine and fluoxetine on the acquisition of the conditioned avoidance response in rats.
    McElroy JF; Du Pont AF; Feldman RS
    Psychopharmacology (Berl); 1982; 77(4):356-9. PubMed ID: 6813897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
    Callaway CW; Wing LL; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.